Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Houslay

Showing results (181-190 of 273) with videos related to

Pageof 28
Sort By:
FEBS Letters|March 1, 1975
Lipid phase transitions control beta-hydroxybutyrate dehydrogenase activity in defined-lipid protein complexesM D Houslay, G B Warren, N J Birdsall, et al.
The Biochemical Journal|September 15, 1983
The lipid fluidity of rat liver membrane subfractionsA D Whetton, M D Houslay, N J Dodd, et al.
Journal of Cellular Biochemistry|January 1, 1994
Regulation of hepatocyte adenylate cyclase by amylin and CGRP: a single receptor displaying apparent negative cooperatively towards CGRP and simple saturation kinetics for amylin, a requirement for phosphodiesterase inhibition to observe elevated hepatocyte cyclic AMP levels and the phosphorylation of Gi-2M D Houslay, N J Morris, A Savage, et al.
The Biochemical Journal|August 15, 1984
An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrationsC M Heyworth, A V Wallace, S R Wilson, et al.
The Journal of Biological Chemistry|July 12, 1996
Determination of the structure of the N-terminal splice region of the cyclic AMP-specific phosphodiesterase RD1 (RNPDE4A1) by 1H NMR and identification of the membrane association domain using chimeric constructsK J Smith, G Scotland, J Beattie, et al.
Cellular Signalling|February 1, 1996
Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipramA M Michie, M Lobban, T Müller, et al.
Brain Research. Developmental Brain Research|September 15, 2001
Development of rolipram-sensitive, cyclic AMP phosphodiesterase (PDE4) in rat primary neuronal culturesY Ye, K Jackson, M D Houslay, et al.
Biochemical Society Transactions|February 1, 1995
Modulation of adenosine signalling in sheep adipose tissue by growth hormoneR Doris, E Kilgour, M D Houslay, et al.
The Biochemical Journal|November 15, 1989
Adipocyte plasma-membrane Gi and Gs in insulinopenic diabetic patientsJ J Ohisalo, H L Vikman, S Ranta, et al.
The Biochemical Journal|June 26, 1998
cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular modelR Hoffmann, I R Wilkinson, J F McCallum, et al.
Pageof 28

Showing results (181-190 of 273) with videos related to

Sort By:
Pageof 28
FEBS Letters|March 1, 1975
Lipid phase transitions control beta-hydroxybutyrate dehydrogenase activity in defined-lipid protein complexesM D Houslay, G B Warren, N J Birdsall, et al.
The Biochemical Journal|September 15, 1983
The lipid fluidity of rat liver membrane subfractionsA D Whetton, M D Houslay, N J Dodd, et al.
Journal of Cellular Biochemistry|January 1, 1994
Regulation of hepatocyte adenylate cyclase by amylin and CGRP: a single receptor displaying apparent negative cooperatively towards CGRP and simple saturation kinetics for amylin, a requirement for phosphodiesterase inhibition to observe elevated hepatocyte cyclic AMP levels and the phosphorylation of Gi-2M D Houslay, N J Morris, A Savage, et al.
The Biochemical Journal|August 15, 1984
An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrationsC M Heyworth, A V Wallace, S R Wilson, et al.
The Journal of Biological Chemistry|July 12, 1996
Determination of the structure of the N-terminal splice region of the cyclic AMP-specific phosphodiesterase RD1 (RNPDE4A1) by 1H NMR and identification of the membrane association domain using chimeric constructsK J Smith, G Scotland, J Beattie, et al.
Cellular Signalling|February 1, 1996
Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipramA M Michie, M Lobban, T Müller, et al.
Brain Research. Developmental Brain Research|September 15, 2001
Development of rolipram-sensitive, cyclic AMP phosphodiesterase (PDE4) in rat primary neuronal culturesY Ye, K Jackson, M D Houslay, et al.
Biochemical Society Transactions|February 1, 1995
Modulation of adenosine signalling in sheep adipose tissue by growth hormoneR Doris, E Kilgour, M D Houslay, et al.
The Biochemical Journal|November 15, 1989
Adipocyte plasma-membrane Gi and Gs in insulinopenic diabetic patientsJ J Ohisalo, H L Vikman, S Ranta, et al.
The Biochemical Journal|June 26, 1998
cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular modelR Hoffmann, I R Wilkinson, J F McCallum, et al.
Pageof 28